CNS Pharmaceuticals, Inc.CNS Pharmaceuticals, Inc.CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪528.60 K‬USD
−174.04USD
‪−18.85 M‬USD
‪228.95 K‬
Beta (1Y)
−0.04

About CNS Pharmaceuticals, Inc.

CEO
John M. Climaco
Headquarters
Houston
Employees (FY)
5
Founded
2017
FIGI
BBG00PM24T16
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CNSP is 2.84 USD — it has increased by 27.35% in the past 24 hours. Watch CNS Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CNS Pharmaceuticals, Inc. stocks are traded under the ticker CNSP.
CNSP stock has risen by 7.17% compared to the previous week, the month change is a 73.61% fall, over the last year CNS Pharmaceuticals, Inc. has showed a 97.54% decrease.
CNSP reached its all-time high on Nov 19, 2019 with the price of 8534.85 USD, and its all-time low was 1.98 USD and was reached on Jun 21, 2024. View more price dynamics on CNSP chart.
See other stocks reaching their highest and lowest prices.
CNSP stock is 77.63% volatile and has beta coefficient of −0.04. Track CNS Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is CNS Pharmaceuticals, Inc. there?
Today CNS Pharmaceuticals, Inc. has the market capitalization of ‪528.60 K‬, it has decreased by 15.94% over the last week.
Yes, you can track CNS Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
CNS Pharmaceuticals, Inc. is going to release the next earnings report on Aug 12, 2024. Keep track of upcoming events with our Earnings Calendar.
CNSP net income for the last quarter is ‪−3.54 M‬ USD, while the quarter before that showed ‪−5.38 M‬ USD of net income which accounts for 34.05% change. Track more CNS Pharmaceuticals, Inc. financial stats to get the full picture.
No, CNSP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 25, 2024, the company has 5.00 employees. See our rating of the largest employees — is CNS Pharmaceuticals, Inc. on this list?
Like other stocks, CNSP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CNS Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CNS Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CNS Pharmaceuticals, Inc. stock shows the sell signal. See more of CNS Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.